Payne Christopher D reported grant involving 810 derivative units of Hims Hers Health, Inc. at $0.00 for $0 on Nov 11, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Nov 13, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
810Restricted Stock Unit
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
810Direct
Trade date
Nov 11, 2026Grant
Filed
Nov 13, 2026, 4:17 PM ET2-day reporting delay
Accession
0001773751-26-000256Code A · Transaction 400652
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

HIMS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HIMS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +55%1w ago +35%1d ago −3%
Returns since7d30d90d180d1y

Footnotes in full

F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the third quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,125 by the grant price of $28.53. The RSUs will vest in full on the Company's next quarterly vesting date.